PharVision Advisers’s CMS Energy CMS Stock Holding History

PharVision Advisers’s Portfolio CMS Stock Details CMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,747	Closed	-$206K	–	295
2025 Q1	$206K	Buy	+2,747	New	+$192K	0.29%	194

Other funds holding CMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PharVision Advisers's CMS Position: Q2 2025 in Review

PharVision Advisers sold out of CMS Energy (CMS) in Q2 2025, closing a stake of 2,747 shares — an estimated $206K sold.

PharVision Advisers first reported a position in CMS in Q1 2025 and held it in 1 quarter. The position peaked at $206K in Q1 2025. 744 funds tracked by Wall St. Rank hold CMS as of Q2 2025.

PharVision Advisers reported no remaining CMS Energy position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 2,747 CMS Energy shares in Q2 2025, an estimated $206K.
PharVision Advisers first reported a position in CMS Energy in Q1 2025 and held it in 1 quarter.
PharVision Advisers's CMS Energy position peaked at $206K in Q1 2025.
744 funds tracked by Wall St. Rank held CMS Energy as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.